EDAP - שווי פעילות edap-tms.com

EDAP TMS S.A. (EDAP) is implementing robotic methods for treating prostate tumors, replacing full-scale surgeries with outpatient ultrasound treatment. Profit growth is driven by the supply of high-cost systems and the sale of associated consumables. The current business valuation is 174.69. The price action below demonstrates the market position of the company, which maintains leadership in the field of non-invasive HIFU therapy.

EDAP TMS S.A. produces specialized urological equipment, for which demand remains stable due to government health insurance. By analyzing the enterprise value, an investor can determine the total cost of acquiring the business. This metric sums the market capitalization and debt obligations, subtracting liquid cash. This allows for an objective valuation of the company, eliminating the impact of short-term market volatility. Low values for this metric require caution to avoid falling into a value trap.